In the BioHarmony Drug Report Database

"Preview" Icon

Tegafur

Teysuno (tegafur) is a small molecule pharmaceutical. Tegafur was first approved as Teysuno on 2011-03-14. It has been approved in Europe to treat stomach neoplasms. It is known to target dihydropyrimidine dehydrogenase [NADP(+)].

 

Trade Name

 

Teysuno
 

Common Name

 

tegafur
 

ChEMBL ID

 

CHEMBL20883
 

Indication

 

stomach neoplasms
 

Drug Class

 

Image (chem structure or protein)

Tegafur structure rendering